Emi Gunji

TS-071 is a novel, potent and selective renal sodium-glucose cotransporter 2 (SGLT2) inhibitor with anti-hyperglycaemic activity

Koji Yamamoto, Shusaku Uchida, Kiyokazu Kitano et al. · British Journal of Pharmacology · 2011 · 66 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Molecular Dissection of the Mechanisms of Substrate Recognition and F-actin-mediated Activation of Cofilin-phosphatase Slingshot-1

Souichi Kurita, Yosuke Watanabe, Emi Gunji et al. · Journal of Biological Chemistry · 2008 · 55 citations · Full text

Life Sciences, Biochemistry, Cell Biology +16

Actin filaments‐stabilizing and ‐bundling activities of cofilin‐phosphatase Slingshot‐1

Souichi Kurita, Emi Gunji, Kazumasa Ohashi et al. · Genes to Cells · 2007 · 39 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

In vitro characterization of luseogliflozin, a potent and competitive sodium glucose co-transporter 2 inhibitor: Inhibition kinetics and binding studies

Saeko Uchida, Akiko Mitani, Emi Gunji et al. · Journal of Pharmacological Sciences · 2015 · 15 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

SGL5213, a novel and potent intestinal SGLT1 inhibitor, suppresses intestinal glucose absorption and enhances plasma GLP-1 and GLP-2 secretion in rats

Fusayo Io, Emi Gunji, Hiroko Koretsune et al. · European Journal of Pharmacology · 2019 · 13 citations

Medicine, Endocrinology, Pharmacology +15